New England Biolabs' (NEB) attention to quality assurance (QA) and quality control (QC) is second to none. After all, its not just manufacturing enzymes that can be used in the various stages of discovering a new drug, the company also uses them in its own product research and development (R&D) efforts.

To help its customers reduce risk and respond to regulatory requirements while meeting their large-scale production needs, NEB recently broke ground on a new good manufacturing practice (GMP) manufacturing facility for reagents used in more regulated applications and markets.

The company is fully compliant and certified to internationally recognised quality standards, including the International Standards Organisation (ISO) 9001:2008 and ISO 13485:2003.